PreveCeutical Medical Inc (18H) — Cash Flow Reinvestment Rate

Latest as of September 2021: 0.00x

PreveCeutical Medical Inc (18H) has a Cash Flow Reinvestment Rate of 0.00x as of September 2021, reinvesting €0.00 (capex €0.00 ) from operating cash flow of €231.85K. See 18H free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

€0.00
Capex + Investments

Operating Cash Flow

€231.85K
EUR

Capital Expenditures

€0.00
EUR

PreveCeutical Medical Inc Cash Flow Reinvestment Rate (2020–2020)

Historical reinvestment intensity for PreveCeutical Medical Inc across 1 annual periods. For the full cash flow conversion analysis, see PreveCeutical Medical Inc (18H) cash conversion ratio.

Annual Cash Flow Reinvestment Rate for PreveCeutical Medical Inc (2020–2020)

Year-by-year capital reinvestment analysis for PreveCeutical Medical Inc. See PreveCeutical Medical Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (EUR) Operating CF Capex YoY Change
2020 0.08x €5.30K €64.59K €2.65K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow